Sathvik Sagi
@idsvs37.bsky.social
Novavax signs licensing agreement with Pfizer for vaccine development.
Novavax signed a licensing deal giving Pfizer access to its vaccine technology to boost immune responses for up to two infectious diseases, sending Novavax shares up nearly 7%.
Novavax signed a licensing deal giving Pfizer access to its vaccine technology to boost immune responses for up to two infectious diseases, sending Novavax shares up nearly 7%.
Novavax signs licensing agreement with Pfizer for vaccine development
Novavax said on Tuesday it signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, and the smaller co...
www.reuters.com
January 25, 2026 at 1:13 AM
"Almost 30 million Americans are walking around saying, ‘I’m allergic to penicillin,’ and they really are not,” says Bruce Jones, PharmD, BCPS, infectious diseases clinical pharmacy specialist. www.sjchs.org/resource-hub...
January 25, 2026 at 1:11 AM